Literature DB >> 24652619

A one-step imaging assay to monitor cell cycle state and apoptosis in mammalian cells.

Yangzhong Tang1,2.   

Abstract

High-content screening (HCS; fluorescence microscopy with multiple markers followed by automated image analysis) is gaining popularity in drug discovery due to the rich information it reveals about drug responses. It is particularly useful in studying anti-mitotic drug responses since mitotic arrest provides an activity biomarker. One conventional way to probe mitotic arrest and downstream apoptosis response is to use mitosis- and apoptosis-specific antibodies in cell-based imaging assays. However, weakly attached cells, especially dead cells, are mostly washed out during antibody labeling steps. Here, we report a rapid and convenient one-step cell-imaging assay that accurately measures cell-cycle state and apoptosis in mammalian cells. The assay uses three fluorescent dyes to stain living cells, involves no wash, and is fixable after live-cell labeling. Compared to the antibody-based method, this assay is quicker, more cost-effective, and yields more accurate dose-response results.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  apoptosis; dose response; high-content screening; imaging assay; mitosis; pharmacology

Mesh:

Year:  2014        PMID: 24652619      PMCID: PMC4016950          DOI: 10.1002/9780470559277.ch130140

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  9 in total

Review 1.  High content screening: seeing is believing.

Authors:  Fabian Zanella; James B Lorens; Wolfgang Link
Journal:  Trends Biotechnol       Date:  2010-03-24       Impact factor: 19.536

Review 2.  Cellular imaging in drug discovery.

Authors:  Paul Lang; Karen Yeow; Anthony Nichols; Alexander Scheer
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

Review 3.  Microscopic imaging techniques for drug discovery.

Authors:  Andrew Bullen
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

4.  Overview of liquid handling instrumentation for high-throughput screening applications.

Authors:  Stewart Rudnicki; Sean Johnston
Journal:  Curr Protoc Chem Biol       Date:  2009-12-01

Review 5.  Pharmacogenetics, pharmacogenomics, and individualized medicine.

Authors:  Qiang Ma; Anthony Y H Lu
Journal:  Pharmacol Rev       Date:  2011-03-24       Impact factor: 25.468

Review 6.  Relating human genetic variation to variation in drug responses.

Authors:  Ashraf G Madian; Heather E Wheeler; Richard Baker Jones; M Eileen Dolan
Journal:  Trends Genet       Date:  2012-07-26       Impact factor: 11.639

Review 7.  Diagnosing and exploiting cancer's addiction to blocks in apoptosis.

Authors:  Anthony G Letai
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

8.  The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis.

Authors:  M J Smyth; E Krasovskis; V R Sutton; R W Johnstone
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Differential determinants of cancer cell insensitivity to antimitotic drugs discriminated by a one-step cell imaging assay.

Authors:  Yangzhong Tang; Tiao Xie; Stefan Florian; Nathan Moerke; Caroline Shamu; Cyril Benes; Timothy J Mitchison
Journal:  J Biomol Screen       Date:  2013-06-20
  9 in total
  1 in total

1.  Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.

Authors:  Mario Niepel; Marc Hafner; Mirra Chung; Peter K Sorger
Journal:  Curr Protoc Chem Biol       Date:  2017-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.